GTHPGuided Therapeutics, Inc.

About Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics, Inc. (GTHP) is a Medical Devices company headquartered in Peachtree Corners, GA, United States whose shares trade over-the-counter on the OTCQB tier.

Guided Therapeutics, Inc. is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. LuViva works by shining light on the cervical and reading the returned light with a spectrometer. LuViva looks for chemical and physical markers of precancer. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. For more information, visit www.guidedinc.com.

Products and services

Medical Devices

GTHP key facts

Ticker symbol

GTHP

Market tier

OTCQB

Sector

Healthcare

Industry

Medical Devices

Headquarters

Peachtree Corners, GA, United States

Country of incorporation

US

Employees

8

Estimated market cap

$7.79M (as of Apr 11, 2025)

Shares outstanding

77,967,594

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Guided Therapeutics, Inc. leadership

• Mark L. Faupel — President, CEO, COO

Explore more: Medical Devices stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with G